Your browser doesn't support javascript.
Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir.
Cramer, Patrick; Kokic, Goran; Dienemann, Christian; Höbartner, Claudia; Hillen, Hauke S.
  • Cramer P; Abteilung Molekularbiologie, Max-Planck-Institut für biophysikalische Chemie, Am Fassberg 11, D-37077 Göttingen, Deutschland.
  • Kokic G; Abteilung Molekularbiologie, Max-Planck-Institut für biophysikalische Chemie, Am Fassberg 11, D-37077 Göttingen, Deutschland.
  • Dienemann C; Abteilung Molekularbiologie, Max-Planck-Institut für biophysikalische Chemie, Am Fassberg 11, D-37077 Göttingen, Deutschland.
  • Höbartner C; Institut für Organische Chemie, Universität Würzburg, WüRzburg, Deutschland.
  • Hillen HS; Abteilung Molekularbiologie, Max-Planck-Institut für biophysikalische Chemie, Am Fassberg 11, D-37077 Göttingen, Deutschland.
Biospektrum (Heidelb) ; 27(1): 49-53, 2021.
Article in German | MEDLINE | ID: covidwho-1092773
ABSTRACT
Coronaviruses use an RNA-dependent RNA polymerase to replicate and transcribe their RNA genome. The structure of the SARS-CoV-2 polymerase was determined by cryo-electron microscopy within a short time in spring 2020. The structure explains how the viral enzyme synthesizes RNA and how it replicates the exceptionally large genome in a processive manner. The most recent structure-function studies further reveal the mechanism of polymerase inhibition by remdesivir, an approved drug for the treatment of COVID-19.

Full text: Available Collection: International databases Database: MEDLINE Language: German Journal: Biospektrum (Heidelb) Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Language: German Journal: Biospektrum (Heidelb) Year: 2021 Document Type: Article